April 17 (Reuters) - Orexo AB ORX.ST :
* OREXO EXTENDS PATENT PROTECTION FOR ITS NASAL EPINEPHRINE
POWDER
PRODUCT OX640 IN THE US
* UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
GRANTED
ANOTHER US PATENT SPECIFICALLY RELATED TO OX640
* NEWLY ISSUED PATENT, US PATENT NO. 11,957,647, PROVIDES
BOTH
EXPANDED SCOPE OF PROTECTION AS WELL AS LONGER PATENT TERM, NOW
EXTENDING UNTIL NOVEMBER 2042
* EXPECTS TO CONTINUOUSLY STRENGTHEN PATENT PORTFOLIO FOR
OX640.
Source text for Eikon: ID:nWkr5z8N94
Further company coverage: ORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))